1. Functional interplay between long non-coding RNAs and Breast CSCs
   Bashdar Mahmud Hussen et al, 2022, Cancer Cell Int CrossRef
2. Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
   Sunny Kumar et al, 2022, Genes & Diseases CrossRef
3. Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells
   Maryam Farzaneh et al, 2023, Clin Transl Oncol CrossRef
4. LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer
   Marco Antonio Fonseca-Montaño et al, 2023, Front. Genet. CrossRef
5. The current advances of lncRNAs in breast cancer immunobiology research
   Marco Antonio Fonseca-Montaño et al, 2023, Front. Immunol. CrossRef
6. The MALAT1-breast cancer interplay: insights and implications
   Muhammad Tufail, 2023, Expert Review of Molecular Diagnostics CrossRef
7. The Role of LncRNA XIST in Gynecologic Cancers
   Razieh Mohammad Jafari et al, 2023, CCTR CrossRef
8. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer.
   Qiuhui Yang et al, 2023, J Zhejiang Univ Sci B CrossRef
9. Prognostic value of lncRNA LINC01018 in prostate cancer by regulating miR-182-5p (The role of LINC01018 in prostate cancer)
   Wentao Luo et al, 2023, Nucleosides, Nucleotides & Nucleic Acids CrossRef
10. Potential therapies for non-coding RNAs in breast cancer
    Ruonan Li et al, 2024, Front. Oncol. CrossRef